PRM65 Should We Aggregate Cost-Effectiveness over an Intervention's Entire Implementation Lifetime?

Cost, production, efficiency, or effectiveness: where should we focus?

Across all countries, costs of care are increasing, and so increased prevention of disease is widely thought to mean reduced costs in the future. Although this assumption might be true for the disease being prevented, increased prevention will mean that populations live longer (a good thing of course), and as a result adopt diff erent disease profi les. As population profi les change, demand fo...

How should we aggregate competing claims ?

Cost-effectiveness of coronary interventions.

As the costs of medical care continue to rise, there has been increasing interest in evaluating the cost-effectiveness of medical practices. One area that has received particular scrutiny in recent years is percutaneous coronary revascularisation (PTCA). In the United States alone, more than 300 000 PTCAs are performed each year at an estimated cost of approximately US$3 billion. Despite the tr...

Cost-Effectiveness Analysis of Health Interventions: A Critical Review

Background and Aim: Economic evaluation of health interventions by comparing the relevant costs and benefits will result in optimum allocation of resources and increasing the effectiveness of the health system and, through improving equity and increasing accessibility to health services, will lead to increased effectiveness of the health system. The purpose of this study was to critically evalu...

Which Measure of Aggregate Output Should We Use ?

Aggregate output is a focal point of macroeconomics. In the empirical literature, a number of variables are used as a proxy for aggregate output. In this paper, we compare the temporal behavior of four monthly measures of aggregate output: namely GDP, ICI, IP, and XCI. These four measures of output are found to have a common long-run permanent component but distinct short-run cyclical patterns....